Trimetazidine Protects Against Cardiac Ischemia/reperfusion Injury Via Effects on Cardiac MiRNA‑21 Expression, Akt and the Bcl‑2/Bax Pathway

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2016 Sep 27

PMID 27666568

Citations 31

Authors

Ning Ma

Jingyun Bai

Weihua Zhang

Hong Luo

Xin Zhang

Donghai Liu

Chenhui Qiao

Affiliations

Soon will be listed here.

Abstract

Trimetazidine is a piperazine-derived metabolic agent, which exerts cell protective effects and has been reported to be efficient in the treatment of chronic stable angina pectoris. In addition, it has been shown to exert protection against acute myocardial infarction. The present study aimed to investigate whether trimetazidine protects against cardiac ischemia/reperfusion (I/R) injury, and to determine whether its curative effects are associated with microRNA (miRNA)‑21 expression, Akt, and the B‑cell lymphoma 2 (Bcl‑2)/Bcl‑2‑associated X protein (Bax) pathway. Cardiac I/R injury was induced by ligating the left anterior descending coronary artery in adult rats. Subsequently, cardiac function was evaluated, and the expression levels of miRNA‑21, Bcl‑2, Bax and phosphorylated‑Akt were detected using quantitative polymerase chain reaction and western blotting. The results indicated that trimetazidine was able to significantly protect cardiac function and reduce infarct size in rats following cardiac I/R injury. Furthermore, trimetazidine significantly promoted miRNA‑21 expression and phosphorylated‑Akt protein expression, and reduced the Bcl‑2/Bax ratio in rats following cardiac I/R injury. Knockdown of miRNA‑21 using anti‑miR‑21 plasmids was able to reverse the protective effects of trimetazidine against cardiac I/R injury. These results indicated that miRNA‑21 serves a protective role in cardiac I/R injury via Akt and the Bcl‑2/Bax pathway. In addition, trimetazidine exerts protective effects against cardiac I/R injury through cardiac miRNA‑21 expression, Akt, and the Bcl‑2/Bax pathway. Therefore, the present study provided evidence regarding the protective effects of miRNA‑21 on cardiac I/R injury following treatment with trimetazidine in vivo.

Citing Articles

A Machine Learning Approach to Gene Expression in Hypertrophic Cardiomyopathy.

Pavic J, Zivanovic M, Tanaskovic I, Pavic O, Stankovic V, Virijevic K Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39459004 PMC: 11510441. DOI: 10.3390/ph17101364.

An intrinsic mechanism of metabolic tuning promotes cardiac resilience to stress.

Sorge M, Savore G, Gallo A, Acquarone D, Sbroggio M, Velasco S EMBO Mol Med. 2024; 16(10):2450-2484.

PMID: 39271959 PMC: 11473679. DOI: 10.1038/s44321-024-00132-z.

Is Intrinsic Cardioprotection a Laboratory Phenomenon or a Clinically Relevant Tool to Salvage the Failing Heart?.

Ravingerova T, Adameova A, Lonek L, Farkasova V, Ferko M, Andelova N Int J Mol Sci. 2023; 24(22).

PMID: 38003687 PMC: 10671596. DOI: 10.3390/ijms242216497.

Cardioprotective Strategies After Ischemia-Reperfusion Injury.

Zhang H, Hu H, Zhai C, Jing L, Tian H Am J Cardiovasc Drugs. 2023; 24(1):5-18.

PMID: 37815758 PMC: 10806044. DOI: 10.1007/s40256-023-00614-4.

A review on experimental surgical models and anesthetic protocols of heart failure in rats.

Farag A, Mandour A, Hendawy H, Elhaieg A, Elfadadny A, Tanaka R Front Vet Sci. 2023; 10:1103229.

PMID: 37051509 PMC: 10083377. DOI: 10.3389/fvets.2023.1103229.

References

Jansen F, Yang X, Proebsting S, Hoelscher M, Przybilla D, Baumann K . MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am Heart Assoc. 2014; 3(6):e001249. PMC: 4338711. DOI: 10.1161/JAHA.114.001249. View

Zhou J, Zhang J . Identification of miRNA-21 and miRNA-24 in plasma as potential early stage markers of acute cerebral infarction. Mol Med Rep. 2014; 10(2):971-6. DOI: 10.3892/mmr.2014.2245. View

Wang Y, Zhang Z, Wu Y, Zhan J, He X, Wang Y . Honokiol protects rat hearts against myocardial ischemia reperfusion injury by reducing oxidative stress and inflammation. Exp Ther Med. 2012; 5(1):315-319. PMC: 3523945. DOI: 10.3892/etm.2012.766. View

Damania P, Sen B, Dar S, Kumar S, Kumari A, Gupta E . Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN). PLoS One. 2014; 9(3):e91745. PMC: 3954734. DOI: 10.1371/journal.pone.0091745. View

Song J, Teng X, Cai Y, Tang C, Qi Y . Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion. Apoptosis. 2009; 14(11):1299-307. DOI: 10.1007/s10495-009-0398-7. View

Zhang X, Xiong Z, Tang A, Ma H, Ma Y, Wu J . Rosiglitazone-induced myocardial protection against ischaemia-reperfusion injury is mediated via a phosphatidylinositol 3-kinase/Akt-dependent pathway. Clin Exp Pharmacol Physiol. 2009; 37(2):156-61. DOI: 10.1111/j.1440-1681.2009.05232.x. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Chua C, Gao J, Ho Y, Xu X, Kuo I, Chua K . Over-expression of a modified bifunctional apoptosis regulator protects against cardiac injury and doxorubicin-induced cardiotoxicity in transgenic mice. Cardiovasc Res. 2008; 81(1):20-7. PMC: 2639090. DOI: 10.1093/cvr/cvn257. View

Khan M, Meduru S, Mostafa M, Khan S, Hideg K, Kuppusamy P . Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling. J Pharmacol Exp Ther. 2010; 333(2):421-9. PMC: 2872960. DOI: 10.1124/jpet.109.165175. View

10.

Lencova-Popelova O, Jirkovsky E, Mazurova Y, Lenco J, Adamcova M, Simunek T . Molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up. PLoS One. 2014; 9(5):e96055. PMC: 4013127. DOI: 10.1371/journal.pone.0096055. View

11.

Kutala V, Khan M, Mandal R, Ganesan L, Tridandapani S, Kalai T . Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties. J Pharmacol Exp Ther. 2006; 317(3):921-8. DOI: 10.1124/jpet.105.100834. View

12.

Ikeda S, Pu W . Expression and function of microRNAs in heart disease. Curr Drug Targets. 2010; 11(8):913-25. DOI: 10.2174/138945010791591304. View

13.

Liu F, Yin L, Zhang L, Liu W, Liu J, Wang Y . Trimetazidine improves right ventricular function by increasing miR-21 expression. Int J Mol Med. 2012; 30(4):849-55. DOI: 10.3892/ijmm.2012.1078. View

14.

Qiao Z, Ma J, Liu H . Evaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury. Molecules. 2011; 16(12):10002-12. PMC: 6264289. DOI: 10.3390/molecules161210002. View

15.

Yin C, Wang X, Kukreja R . Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice. FEBS Lett. 2008; 582(30):4137-42. PMC: 3031789. DOI: 10.1016/j.febslet.2008.11.014. View

16.

Liu Z, Li Z, Liu X . Effect of ginsenoside Re on cardiomyocyte apoptosis and expression of Bcl-2/Bax gene after ischemia and reperfusion in rats. J Huazhong Univ Sci Technolog Med Sci. 2003; 22(4):305-9. DOI: 10.1007/BF02896771. View

17.

Hoda M, Siddiqui S, Herberg S, Periyasamy-Thandavan S, Bhatia K, Hafez S . Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke. Stroke. 2012; 43(10):2794-9. PMC: 3740528. DOI: 10.1161/STROKEAHA.112.660373. View

18.

Li X, Liu J, Lin L, Guo Y, Lin C, Zhang C . Traditional chinese medicine shuang shen ning xin attenuates myocardial ischemia/reperfusion injury by preserving of mitochondrial function. Evid Based Complement Alternat Med. 2014; 2014:180965. PMC: 4083608. DOI: 10.1155/2014/180965. View

19.

Allibardi S, Chierchia S, Margonato V, Merati G, Neri G, DellAntonio G . Effects of trimetazidine on metabolic and functional recovery of postischemic rat hearts. Cardiovasc Drugs Ther. 1999; 12(6):543-9. DOI: 10.1023/a:1007731219206. View

20.

Opie L, Boucher F . Trimetazidine and myocardial ischemic contracture in isolated rat heart. Am J Cardiol. 1995; 76(6):38B-40B. View